Pharmaceutical

CSL completed construction in September of 2022 on its $150 million R&D campus in Marburg, Germany. Located in the Görzhausen Industrial Park, the 430,000-sf facility offers sophisticated environments for the creation of next-generation mRNA vaccines, recombinant technologies, and cell and gene therapies. Accommodating up to 500 employees, the multidisciplinary complex represents CSL’s largest global research hub with 75,000 sf of lab space and 75,000 sf of office space.

Sartorius is constructing the $60 million Center of Excellence for BioAnalytics in Ann Arbor, Mich. Designed by Hobbs+Black Architects, the 130,000-sf building will include a process development lab to accelerate the creation of advanced medical therapies. Providing next-generation facilities for biopharmaceutical research, development, production, and testing, the project will enable the company to consolidate business operations currently dispersed throughout Washtenaw County and beyond.

Thermo Fisher Scientific opened a 300,000-sf viral vector center in August of 2022 in Plainville, Mass. Accelerating the creation of advanced cell and gene therapies, the cGMP-compliant facility offers flexible laboratories and production suites for the development, testing, and manufacture of viral vectors. Featuring Thermo Fisher’s advanced bioprocessing technologies and analytical instrumentation, the sustainably designed structure also includes sophisticated office environments and adjacent warehouse spaces.

Pfizer is expanding its Chesterfield campus with the construction of a $60 million addition to support vaccine research and development. Providing leading-edge labs, offices, and support spaces, the three-story, 37,000-sf project will adjoin an existing 261,000-sf facility that opened in 2019. A two-story bridge with a covered plaza will link the completed structure to the rest of the 31-acre site. 

Breakthrough Properties began construction in August of 2022 on the One Canal life sciences center in Cambridge, Mass. Designed to accommodate either a single tenant or multiple companies, the project involves the renovation of an existing structure to provide 105,000 sf of best-in-class biomedical research space. Occupants will enjoy private outdoor meeting venues, integrated retail amenities, and a fitness center.

Longfellow Real Estate Partners broke ground in August of 2022 on a 323,000-sf life sciences center in San Diego. Designed by HOK, the six-story Bioterra development will provide leading-edge laboratories, offices, and collaboration spaces for biomedical and pharmaceutical tenants. Occupants will enjoy a lush rooftop patio offering inspiring views, with specially curated food and beverage options on the lower levels open to the public.

BioMed Realty is constructing a 495,000-sf life sciences facility at Assembly Innovation Park in Somerville, Mass. Designed by Perkins&Will, the 12-story lab and office tower will provide leasable research environments for biomedical, pharmaceutical, and technology companies. With a floor-to-floor height of 15 feet, the building will offer floor plates of approximately 45,000 sf serviced by robust mechanical and electrical infrastructure.

Lincoln Property Company is planning to break ground in early 2023 on a 650,000-sf life sciences center in Boston. Designed by Arrowstreet, Moody Nolan, and Studio Eneé, Seaport Circle will provide Class A lab and office environments for biomedical and pharmaceutical tenants. Two adjoining towers topped by green roof decks will offer flexible, column-free floor plates ranging from 25,000 sf to 70,000 sf.

The University of Cambridge opened the Heart and Lung Research Institute in the United Kingdom in July of 2022. Created in partnership with the Royal Papworth Hospital NHS Foundation Trust, the £60 million facility features state-of-the-art labs for cellular, molecular, and translational research. Accommodating 380 academic and industry scientists, the 86,000-sf project houses a high-throughput characterization suite, a genetics and functional genomic center, the relocated Cardiovascular Epidemiology Unit, and the 10-bed Clinical Research Facility.

Albany College of Pharmacy and Health Sciences has acquired an existing life sciences facility to house the Center for Biopharmaceutical Education and Training. Sited adjacent to the school's campus in Albany, New York, the 154,000-sf structure is uniquely designed for biomedical research with over 60,000 sf of BSL-2 and BSL-3 laboratory space. The five-story building will be renovated to create dedicated gene therapy labs, mammalian cell labs, teaching wet labs, biopharmaceutical pilot plants, and fermentation and downstream processing facilities.

Hobbs Brook Real Estate opened a 507,000-sf life sciences complex in June of 2022 in Waltham, Mass. Designed by Gensler, the five-story facility provides state-of-the-art research labs, Class A office environments, and a 150-person conference venue. Integrating advanced mechanical and electrical systems, the highly flexible structure offers column-free floor plates that can be configured to support large single-floor tenants or multiple smaller tenants, with amenities centralized in the core.

Takeda is partnering with BioMed Realty to create a 600,000-sf R&D center in Cambridge. Designed by CBT Architects, the 16-story facility will provide sophisticated lab and office environments for the discovery of next-generation biopharmaceutical therapies and vaccines. Takeda has executed a 15-year lease for all of the research floors in the building, which will feature flexible spaces that maximize in-person interaction and connection under a hybrid working model.

Conscience Bay Company is planning to construct the Ridgeway Science & Technology facility in Boulder, Colo. Designed by Stantec to foster discovery and innovation, the two-story, 112,423-sf development will offer flexible lab and office environments complemented by collaboration spaces, outdoor terraces, shower and locker rooms, secure bike storage, and a café with a fire pit. The high-performance structure will integrate robust mechanical and electrical systems to meet the demands of next-generation research programs.

The University of Pennsylvania and Longfellow Real Estate Partners are planning to construct a 455,000-sf life sciences center on the Pennovation Works property in Philadelphia. Designed by Jacobs, the project will include three structures providing a total of 387,000 sf of R&D space and 68,000 sf of biomanufacturing space for the production of cell and gene therapies.

Growing demand for life sciences research space is driving an increase in office-to-lab conversion projects in the United States. According to a new report from CBRE, office-to-lab conversions in progress in the 12 largest U.S. life sciences markets at the end of 2021 amounted to 9.9 million sf, up 49 percent from the beginning of the year. In comparison, ground-up lab construction rose by 42 percent to nearly 18.8 million sf by the end of 2021.